Par Drugs and Chemicals (NSE:PAR) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

What is Par Drugs and Chemicals LT-Debt-to-Total-Asset?

Par Drugs and Chemicals NSE:PAR -0.04% 81 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates NSE:PAR with a GF Score™ of 81/100 and a GF Value™ of ₹207.85 (Significantly Undervalued). The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Par Drugs and Chemicals's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Par Drugs and Chemicals's long-term debt to total assets ratio stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Par Drugs and Chemicals (NSE:PAR) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Par Drugs and Chemicals LT-Debt-to-Total-Asset Related Terms

Par Drugs and Chemicals LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Par Drugs and Chemicals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Par Drugs and Chemicals LT-Debt-to-Total-Asset Chart

Par Drugs and Chemicals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

Par Drugs and Chemicals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

81GF Score

Par Drugs and Chemicals Ltd NSE:PAR

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Par Drugs and Chemicals LT-Debt-to-Total-Asset Calculation

Par Drugs and Chemicals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )	/	Total Assets (A: Mar. 2026 )
	=	0	/	1292.123
	=	0.00

Par Drugs and Chemicals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	0	/	1292.123
	=	0.00

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Par Drugs and Chemicals (NSE:PAR) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Par Drugs and Chemicals and its competitors.

Is Par Drugs and Chemicals' LT-Debt-to-Total-Asset too high?

Par Drugs and Chemicals' current LT-Debt-to-Total-Asset is 0.00. Overall, Par Drugs and Chemicals has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Par Drugs and Chemicals' LT-Debt-to-Total-Asset compare to ZTS and UTHR?

Par Drugs and Chemicals' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?

A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Par Drugs and Chemicals and its competitors. Par Drugs and Chemicals's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Par Drugs and Chemicals stock overvalued right now?

Based on GuruFocus' analysis, Par Drugs and Chemicals (NSE:PAR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹207.85, compared to a current price of ₹89.58 — trading 56.9% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Par Drugs and Chemicals' overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Par Drugs and Chemicals (NSE:PAR), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Par Drugs and Chemicals (NSE:PAR) Overvalued in 2026?

Based on GuruFocus' analysis, Par Drugs and Chemicals stock appears to be undervalued. The current stock price of ₹89.58 is trading 56.9% below its estimated GF Value™ of ₹207.85. GuruFocus considers Par Drugs and Chemicals to be Significantly Undervalued.

Key valuation signals for NSE:PAR:

LT-Debt-to-Total-Asset: 0.00
GF Value™: ₹207.85 vs. price of ₹89.58 (56.9% below fair value)
GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the NSE:PAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Par Drugs and Chemicals Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies NSE:SOTAC BOM:530317 BOM:538965 BOM:537536 BOM:538964 NSE:BALAXI BOM:532384 BOM:524202 BOM:524824 BOM:540686 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Address Gotri Vasna Road, 815, Nilamber Triumph, Vadodara, GJ, IND, 390007

Website https://www.pardrugs.com

Par Drugs and Chemicals Ltd manufactures active Pharmaceutical Ingredients (APIs) and fine chemicals, serving domestic and international markets. Specializing in essential magnesium-based compounds and other specialty chemicals such as Magnesium Hydroxide, Magnesium Trisilicate, Magnesium Carbonate, various grades of Magnesium Oxide, Dried Aluminum Hydroxide Gel, and Sucralfate USP, the Company produces high-quality bulk drugs used in the formulation of finished pharmaceutical products like tablets, capsules, and liquids. Committed to maintaining stringent quality standards and utilizing manufacturing processes, the Company plays a vital role in supplying reliable ingredients that ensure the safety, efficacy, and stability of pharmaceutical formulations internationally.

81GF Score

Get the complete analysis for NSE:PAR

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹89.58

Price

₹207.85

GF Value

View NSE:PAR Analysis

See LT-Debt-to-Total-Asset data for all stocks →